What Is Point-of-Care Decision Support — and Why Does It Matter in Value-Based Care?

The Problem It Solves

Physicians make hundreds of clinical decisions a day — often with incomplete information and very little time. Under fee-for-service, decisions can cost the patient and the system, but it rarely shows up on the physician’s own financial radar.

Value-based care changes that. When payment is tied to outcomes and cost, the treatment decision made in the exam room is directly connected to financial performance. The right call at the right moment matters more than it ever did under fee-for-service.

That’s the gap point-of-care decision support is built to close.

In short: Point-of-care decision support gives clinicians the information they need at the exact moment they’re making a treatment decision — evidence-based options, patient-specific costs, and contract-relevant alerts — rather than in a report reviewed days later. In value-based care, it’s the tool that connects each clinical decision to both better outcomes and better financial performance.

What “Point-of-Care” Actually Means

The phrase is simpler than it sounds. Point-of-care means information delivered to the clinician at the exact moment a treatment decision is being made — in the exam room, on the EHR screen, or through a platform open during the patient encounter. Not in a summary reviewed days or weeks later.

That timing is the whole point. Retrospective analytics — the monthly or quarterly reports most practices already have — are useful for spotting trends, but they arrive too late to change a decision that’s already been made. Point-of-care support moves the information upstream, to the moment it can still affect the choice. Knowing in March that a different therapy would have served a patient better doesn’t help the decision that was made in January; the goal is to have that insight in January, before the choice is locked in.

Put simply: retrospective analytics tell you what happened. Point-of-care support helps you decide what to do next, while you can still do it.

What Decision Support Actually Does

A good decision-support tool does a handful of concrete things while the physician is still with the patient:

1. Surfaces the right options. Evidence-based treatment choices matched to the specific patient, not generic guidelines.
2. Shows the cost of each option. A full cost breakdown for every treatment option for that individual patient.
3. Flags lower-cost alternatives. Identifies patients who may be eligible for an optimized or lower-cost therapy that meets the same clinical goal.
4. Warns before a decision goes off-contract. Alerts the physician when a choice is likely to fall outside the parameters of a value-based contract — before it’s locked in.
5. Tracks performance in real time. Measures results against benchmarks as care happens, so there are no surprises at the end of a measurement period.

What this looks like in practice: a physician is weighing two reasonable therapies for a patient. With decision support open during the visit, they can see that the options are comparable on the clinical measures that matter but differ sharply in cost — and that one keeps the patient within the practice’s contract benchmarks while the other pushes outside them. The choice still belongs to the physician. What changes is that it’s now an informed choice made with the full picture, not one revisited months later in a report when nothing can be done about it.

That second point is where OMI Pulse is especially deliberate: it shows the cost breakdown for all treatment options for each individual patient, so physicians can see and understand the full scope of their treatment decisions — and adjust if needed. Taken together, these capabilities turn a value-based contract from something measured after the fact into something a physician can actively manage, one decision at a time.

Why It Matters Most in Specialty Care

Decision support helps everywhere, but specialty care is where it earns its keep.

Specialty treatment is high-cost and high-stakes. A single decision — say, one biologic versus an alternative — can carry major cost implications, with relatively little room for error. Specialty VBC contracts also tend to come with narrow clinical benchmarks that require consistent adherence at the level of each individual encounter, not just the population average.

And under real-world time pressure, even well-intentioned physicians drift from evidence-based pathways — not through carelessness, but simply because the information needed to stay on pathway isn’t in front of them when the decision is made. Real-time support is what keeps the pathway and the practice aligned.

The retrospective approach particularly falls short here. By the time a quarterly report reveals a pattern of off-pathway decisions, the costs are already incurred and the contract performance is already affected. In specialty care, where a handful of high-cost decisions can move the numbers for an entire measurement period, catching the issue at the moment of the decision — rather than the moment of the report — is the difference between managing performance and merely observing it.

The payoff shows up at scale. Across OMI’s program, better-informed decisions at the point of care have helped generate more than $20M in shared savings — drawing on 30,000+ collected outcomes that make each next decision a little better-informed than the last.

How This Connects to Better Outcomes — and Better Financials

Here’s the throughline: when decisions are made with the right information at the right time, clinical outcomes improve and unnecessary costs come out of the system. Under value-based care those two results aren’t in tension — they’re the same result seen from two angles. A patient kept on the right therapy avoids the downstream costs of complications, escalations, and avoidable admissions, which is exactly where value-based savings come from in the first place.

The broader evidence on what value-based care can deliver is covered in our post on the benefits of value-based care. Point-of-care decision support is how those benefits actually get realized at the clinical level. It’s the mechanism, not just the model — the difference between a contract that promises better outcomes and a practice that produces them.

What to Look for in a Platform

If you’re evaluating a decision-support tool, a few things separate the useful from the burdensome:

1. Fits your EHR workflow. It should work inside the steps you already take, not add new ones. A tool that creates extra clicks won’t get used.
2. Pulls from clinical and claims data. One source alone gives a partial picture; the value is in combining them.
3. Adapts to your program and contract. Specialty disease programs and contract types differ — the tool should be configurable to yours, not one-size-fits-all.
4. Reports in real time. Monthly summaries are retrospective by definition. You want to see performance as it happens.
5. Built for specialty care. Tools retrofitted from primary care rarely account for the cost structure and clinical complexity of specialty treatment.

If you also want to understand how these platforms fit into the contract terms themselves, our post on value-based care contracts for specialty providers covers that side in detail.

See It in Practice

OMI Pulse is OMI’s point-of-care decision support platform, built specifically for specialty value-based care. It puts evidence-based options, patient-level cost breakdowns, and real-time performance tracking in front of physicians at the moment care is delivered — while there’s still time to act on it.

See how OMI Pulse supports specialty providers in value-based care programs.